Portola Pharmaceuticals Inc. buy melinda
Start price
01.11.17
/
50%
€49.45
Target price
01.05.18
€55.50
Performance (%)
-28.29%
End price
01.05.18
€35.46
Summary
This prediction ended on 01.05.18 with a price of €35.46. The prediction for Portola Pharmaceuticals Inc. disappointed with a performance of -28.29%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Portola Pharmaceuticals Inc. | 0.012% | 0.012% | -32.057% | -67.867% |
iShares Core DAX® | -1.414% | 7.218% | 17.151% | 15.732% |
iShares Nasdaq 100 | -2.316% | 4.450% | 18.360% | 30.945% |
iShares Nikkei 225® | -2.756% | 10.071% | 10.704% | 2.733% |
iShares S&P 500 | -1.849% | 4.760% | 19.639% | 34.852% |
Comments by melinda for this prediction
In the thread Portola Pharmaceuticals Inc. diskutieren
Inhibitoren der internationalen Markt Inhibitoren der Janus - Kinase und die Möglichkeit einer klinischen Studie Insight 2023
(Laufzeit überschritten)
Stopped prediction by melinda for Portola Pharmaceuticals Inc.
Portola Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€31.89
31.03.19
31.03.19
€36.08
06.07.20
06.07.20
-49.81%
06.07.20
06.07.20
Portola Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€44.60
01.11.17
01.11.17
€50.06
01.05.18
01.05.18
-28.29%
01.05.18
01.05.18
Portola Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€52.50
26.06.17
26.06.17
€63.14
18.07.17
18.07.17
10.70%
18.07.17
18.07.17
Portola Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€18.13
30.03.16
30.03.16
€27.06
07.06.16
07.06.16
35.27%
07.06.16
07.06.16